[1] McPhedran P, Heath CW Jr.Acute leukemia occurring during chronic lymphocytic leukemia.Blood. 1970;35(1):7-11.[2] Roberts KG, Morin RD, Zhang J, et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell. 2012;22(2): 153-166.[3] 中华医学会血液学分会干细胞应用学组.中国异基因造血干细胞移植治疗血液系统疾病专家共识(1)(2014年版) [J].中华血液学杂志, 2014, 38(8): 775-780.[4] Hansen JA, Yamamoto K, Petersdorf E, et al. The role of HLA matching in hematopoietic cell transplantation. Rev Immunogenet. 1999;1(3):359-373.[5] Lv M, Huang XJ. Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go. J Hematol Oncol. 2012;5:10.[6] 黎美章,章卫平,王健民,等.移植物抗宿主病对白血病异基因外周血干细胞移植预后的影响[J].中华血液学杂志, 2014, 35(5): 428-433.[7] Horowitz MM. Does matched unrelated donor transplantation have the same outcome as matched sibling transplantation in unselected patients. Best Pract Res Clin Haematol. 2012; 25(4): 483-486.[8] Ho VT, Kim HT, Aldridge J, et al. Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2011;17(8): 1196-1204.[9] Saber W, Opie S, Rizzo JD, et al. Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia. Blood. 2012;119(17):3908-3916.[10] Hou MF, Hou HA, Lin CT, et al. The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: a Retrospective Study in a Single Center. Journal of Cancer Research and Practice. 2015;2(1): 31-41.[11] Ottinger HD, Ferencik S, Beelen DW, et al. Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors. Blood. 2003;102(3):1131-1137.[12] Klusmann JH, Reinhardt D, Zimmermann M, et al. The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study. Haematologica. 2012;97(1):21-29.[13] Moorman AV, Harrison CJ, Buck GA, et al. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood. 2007;109(8):3189-3197.[14] 郭霞,李强.急性白血病发病机制研究进展[J].实用儿科临床杂志, 2005, 20(7): 690-693.[15] Mori H, Colman SM, Xiao Z, et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci U S A. 2002;99(12):8242-8247.[16] McHale CM, Smith MT. Prenatal origin of chromosomal translocations in acute childhood leukemia: implications and future directions. Am J Hematol. 2004;75(4):254-257.[17] Wiemels JL, Ford AM, Van Wering ER, et al. Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero. Blood. 1999; 94(3): 1057-1062.[18] Greaves MF. Biological models for leukaemia and lymphoma. IARC Sci Publ. 2004;(157):351-372.[19] Greaves MF. Aetiology of acute leukaemia. Lancet. 1997; 349(9048):344-349.[20] Vineis P, Miligi L, Crosignani P, et al. Delayed infection, late tonsillectomy or adenoidectomy and adult leukaemia: a case-control study. Br J Cancer. 2003;88(1):47-49.[21] Gallo RC. A journey with T cells, primate/human retroviruses and other persisting human T-cell tropic viruses. Rev Clin Exp Hematol. 2003;7(4):329-335.[22] Rund D, Ben-Yehuda D. Therapy-related leukemia and myelodysplasia: evolving concepts of pathogenesis and treatment. Hematology. 2004;9(3):179-187.[23] Blanco JG, Edick MJ, Relling MV. Etoposide induces chimeric Mll gene fusions. FASEB J. 2004;18(1):173-175.[24] Stillman WS, Varella-Garcia M, Irons RD. The benzene metabolite, hydroquinone, selectively induces 5q31- and -7 in human CD34+CD19- bone marrow cells. Exp Hematol. 2000; 8(2):169-176.[25] Whysner J, Reddy MV, Ross PM, et al. Genotoxicity of benzene and its metabolites. Mutat Res. 2004;566(2):99-130.[26] Infante-Rivard C. Diagnostic x rays, DNA repair genes and childhood acute lymphoblastic leukemia. Health Phys. 2003; 85(1):60-64.[27] Hromas R, Shopnick R, Jumean HG, et al. A novel syndrome of radiation-associated acute myeloid leukemia involving AML1 gene translocations. Blood. 2000;95(12):4011-4013.[28] Lipshultz SE, Miller TL, Scully RE, et al. Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes. J Clin Oncol. 2012; 30(10):1042-1049.[29] 杨凯,陈惠仁,郭智,等.两种异基因造血干细胞移植治疗白血病的临床观察[J].白血病•淋巴瘤,2015, 24(9): 539-543.[30] Ren HY, Wang LH. 1483 cases of unrelated donor hematopoietic stem cell transplantation-China marrow Donor Program data[A]//中华医学会血液学分会第七次全国造血干细胞移植学术会议论文汇编[C].北京: 中华医学会血液学分会, 北京大学血液学研究所, 2011: 38-43.[31] Gratwohl A. The EBMT risk score. Bone Marrow Transplant. 2012;47(6):749-756.[32] 何军,徐超,吴小津,等.供受者HLA高分辨基因分型不合对非血缘造血干细胞移植患者预后的影响[J].中华血液学杂志, 2012, 33(5): 353-357.[33] 邱大发,许晓军,郭子文,等.同胞相合异基因造血干细胞移植治疗恶性血液病的疗效[J].南昌大学学报:医学版,2011,51(4):41-45.[34] 邱大发,任志娟,简黎,等.非血缘造血干细胞移植治疗白血病30例[J]. 实用医学杂志,2016,32(8): 1314-1317.[35] 于嗣俭. 三种不同供者来源异基因造血干细胞移植治疗急性白血病疗效比较[D]. 广州:南方医科大学, 2015.[36] Thomas ED, Storb R, Clift RA, et al. Bone-marrow transplantation (second of two parts). N Engl J Med. 1975; 292(17):895-902.[37] Warlick ED, Peffault de Latour R, Shanley R, et al. Allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia: similar outcomes regardless of donor type. Biol Blood Marrow Transplant. 2015;21(2):357-363.[38] 顾建华,卓维海.降低儿童X 射线CT 检查辐射剂量的研究进展[J]. 中国医学物理学杂志, 2014, 31(5): 5105-5108.[39] Verneris MR, Lee SJ, Ahn KW, et al. HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant. 2015;21(10):1783-1789.[40] 翁建宇,杜新,凌伟,等.FABC预处理方案同胞异基因造血干细胞移植治疗成人高危急性淋巴细胞白血病[J].实用医学杂志, 2012, 28(5): 772-774. |